Damian Marshall

VP - Analytical Development, Resolution Therapeutics

Damian Marshall is listed as VP - Analytical Development, Resolution Therapeutics. Damian is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.

Compiled from published conference agendas; not yet confirmed by Damian. Is this you? Claim this profile.

About

Damian Marshall is the Vice President of Analytical Development at Resolution Therapeutics, a UK company developing regenerative macrophage therapies for inflammatory and fibrotic diseases. Prior to joining Resolution Damian spent 2 years as VP of Manufacturing Science and Technology at Achilles Therapeutics and 8 years as Director of New Technologies at the Cell and Gene Therapy Catapult. In these roles he led multi-national programmes working on bioprocess automation, PAT integration and advanced product characterisation.

Upcoming

Advanced Therapies Week 2027 19 January 2027 – 21 January 2027

Session 2: Which process and analytical tools have the requisite flexibility, scalability, and cost-effectiveness to enable rapid clinical translation while laying the groundwork for later development and commercialization? Part 2 Speaker · 19 January 2027
Spotlight Speaker · 19 January 2027
Panel discussion Speaker · 20 January 2027
Session 6: Cell therapy product characterization and QC Speaker · 20 January 2027

Spoke alongside

People who have shared a session with Damian at events on B2DB.

Erin Cross Vice President of Development · KROMATID 2 shared sessions
Nolan Polson Vice President, Quality Assurance & Product Quality · Iovance Biotherapeutics, Inc. 2 shared sessions
Therese Choquette CTO · Tigen Pharma 2 shared sessions
Alejandra Gutierrez Guerrero Product Manager, Cell Therapy Biomaterial · Grifols Bio Supplies 1 shared session
Josh Sorafine Senior Vice President Quality and Analytics · Editas Medicine 1 shared session
Mamta Kalra Vice President Process and Analytical Development · Immatics 1 shared session
Steven Falcone COO · Elevatebio 1 shared session